PERFECT MEDICAL (01830) announced its interim results for the six months ended September 30, 2025. Revenue decreased by 21.7% year-on-year to HK$486 million, while profit attributable to equity holders stood at HK$94.8 million, reflecting a 32.7% decline compared to the same period last year. Basic earnings per share were HK7.5 cents, and an interim dividend of HK7.6 cents per share was proposed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments